TR199701121T1 - Benazepril or combination compositions containing benazepril and valsartan. - Google Patents
Benazepril or combination compositions containing benazepril and valsartan.Info
- Publication number
- TR199701121T1 TR199701121T1 TR97/01121T TR9701121T TR199701121T1 TR 199701121 T1 TR199701121 T1 TR 199701121T1 TR 97/01121 T TR97/01121 T TR 97/01121T TR 9701121 T TR9701121 T TR 9701121T TR 199701121 T1 TR199701121 T1 TR 199701121T1
- Authority
- TR
- Turkey
- Prior art keywords
- benazepril
- valsartan
- compositions containing
- combination compositions
- formula
- Prior art date
Links
- XPCFTKFZXHTYIP-PMACEKPBSA-N Benazepril Chemical compound C([C@@H](C(=O)OCC)N[C@@H]1C(N(CC(O)=O)C2=CC=CC=C2CC1)=O)CC1=CC=CC=C1 XPCFTKFZXHTYIP-PMACEKPBSA-N 0.000 title abstract 3
- 229960004530 benazepril Drugs 0.000 title abstract 3
- 239000004072 C09CA03 - Valsartan Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 title abstract 2
- 229960004699 valsartan Drugs 0.000 title abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 208000001647 Renal Insufficiency Diseases 0.000 abstract 1
- MADRIHWFJGRSBP-ROUUACIJSA-N benazeprilat Chemical compound C([C@H](N[C@H]1CCC2=CC=CC=C2N(C1=O)CC(=O)O)C(O)=O)CC1=CC=CC=C1 MADRIHWFJGRSBP-ROUUACIJSA-N 0.000 abstract 1
- 201000006370 kidney failure Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Yüksek tansiyon, kalpte kan basinci yetmezligi ve böbrek yetmezliginin tedavisi için eczasal kombinasyon bilesim, içerisinde (1) formülün ACE-engelleyici benazepril 'i veya formülün benazeprilat 'i veya eczacilikta kullanilan bir tuz bulunur; ve (2) formülün AT1-hasim valsartan 'i veya eczacilikta kullanilan bir tuz bulunur. Ayni zamanda yüksek tansiyon, kalpte kan basinci yetmezligi ve böbrek yetmezliginin tedavisinde kullanildigi gibi.The pharmaceutical combination composition for the treatment of high blood pressure, heart pressure and heart failure, contains (1) ACE-blocking benazepril of the formula or benazeprilate of the formula or a salt used in pharmacy; and (2) AT1-hasim valsartan of formula or a salt used in pharmacy. It is also used in the treatment of high blood pressure, heart pressure failure and kidney failure.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH101295 | 1995-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199701121T1 true TR199701121T1 (en) | 1998-03-21 |
Family
ID=4200393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR97/01121T TR199701121T1 (en) | 1995-04-07 | 1996-04-02 | Benazepril or combination compositions containing benazepril and valsartan. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0820302A1 (en) |
| JP (1) | JPH11503139A (en) |
| KR (1) | KR19980703647A (en) |
| CN (1) | CN1181019A (en) |
| AU (1) | AU5399096A (en) |
| BR (1) | BR9604818A (en) |
| CA (1) | CA2214143A1 (en) |
| CZ (1) | CZ313897A3 (en) |
| HU (1) | HUP9801593A2 (en) |
| MX (1) | MX9707683A (en) |
| NO (1) | NO974400D0 (en) |
| PL (1) | PL322529A1 (en) |
| SK (1) | SK133897A3 (en) |
| TR (1) | TR199701121T1 (en) |
| WO (1) | WO1996031234A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997002032A1 (en) * | 1995-06-30 | 1997-01-23 | Merck & Co., Inc. | Method of treating renal disease using an ace inhibitor and an aii antagonist |
| CN101011390A (en) | 1999-01-26 | 2007-08-08 | 诺瓦提斯公司 | Use of angiotensin II receptor antagonists for treating acute myocardial infarction |
| SK14642002A3 (en) * | 2000-04-12 | 2003-05-02 | Novartis Ag | Combination of at least two compounds selected from an AT1-receptor antagonist or an ACE inhibitor or a HMG-CoA reductase inhibitor groups |
| US20030207930A1 (en) * | 2000-07-19 | 2003-11-06 | Erwin Marti | Valsartan salts |
| PL366419A1 (en) * | 2000-08-22 | 2005-01-24 | Boehringer Ingelheim Pharma Bmbh & Co.Kg | Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors |
| GB0020691D0 (en) * | 2000-08-22 | 2000-10-11 | Boehringer Ingelheim Pharma | Pharmaceutical combination |
| CN1461218A (en) * | 2000-12-18 | 2003-12-10 | 诺瓦提斯公司 | Therapeutic combination of amlodipine and benazepril |
| US6869970B2 (en) | 2002-02-04 | 2005-03-22 | Novartis Ag | Crystalline salt forms of valsartan |
| CN1465712A (en) * | 2002-07-05 | 2004-01-07 | 安徽省生物医学研究所 | Kit, method, software and compound medicine for predicting effect of ACEI antihypertensive medicine |
| JP2006516020A (en) * | 2002-08-28 | 2006-06-15 | キュリス インコーポレイテッド | Co-administration of morphogens and ACE inhibitors in the treatment of chronic renal failure |
| EP1908469A1 (en) | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
| CN101869710A (en) * | 2009-04-24 | 2010-10-27 | 北京奥萨医药研究中心有限公司 | Antihypertensive medical composite |
| DK2432452T3 (en) | 2009-05-20 | 2016-10-10 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutically telmisartan drink solution |
| US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
| CA2938406A1 (en) * | 2014-01-31 | 2015-08-06 | Janssen Pharmaceutica Nv | Methods for the treatment and prevention of renal disorders and fatty liver disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2147875C1 (en) * | 1990-05-11 | 2000-04-27 | Пфайзер Инк. | Method and composition for reducing arterial blood pressure and treating the cases of congestive heart failure in mammals |
| EP0629408A1 (en) * | 1993-06-16 | 1994-12-21 | LABORATOIRES MERCK, SHARP & DOHME-CHIBRET | Combination of angiotensin converting enzyme inhibitors and AII antagonists |
-
1996
- 1996-04-02 MX MX9707683A patent/MX9707683A/en unknown
- 1996-04-02 PL PL96322529A patent/PL322529A1/en unknown
- 1996-04-02 WO PCT/EP1996/001440 patent/WO1996031234A1/en not_active Ceased
- 1996-04-02 KR KR1019970707046A patent/KR19980703647A/en not_active Withdrawn
- 1996-04-02 BR BR9604818A patent/BR9604818A/en not_active Application Discontinuation
- 1996-04-02 TR TR97/01121T patent/TR199701121T1/en unknown
- 1996-04-02 CZ CZ973138A patent/CZ313897A3/en unknown
- 1996-04-02 JP JP8529972A patent/JPH11503139A/en active Pending
- 1996-04-02 AU AU53990/96A patent/AU5399096A/en not_active Abandoned
- 1996-04-02 CN CN96193111A patent/CN1181019A/en active Pending
- 1996-04-02 SK SK1338-97A patent/SK133897A3/en unknown
- 1996-04-02 HU HU9801593A patent/HUP9801593A2/en unknown
- 1996-04-02 CA CA002214143A patent/CA2214143A1/en not_active Abandoned
- 1996-04-02 EP EP96910948A patent/EP0820302A1/en not_active Withdrawn
-
1997
- 1997-09-23 NO NO974400A patent/NO974400D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK133897A3 (en) | 1998-02-04 |
| KR19980703647A (en) | 1998-12-05 |
| NO974400L (en) | 1997-09-23 |
| CN1181019A (en) | 1998-05-06 |
| WO1996031234A1 (en) | 1996-10-10 |
| CA2214143A1 (en) | 1996-10-10 |
| HUP9801593A2 (en) | 1999-01-28 |
| MX9707683A (en) | 1997-12-31 |
| BR9604818A (en) | 1998-06-09 |
| EP0820302A1 (en) | 1998-01-28 |
| NO974400D0 (en) | 1997-09-23 |
| PL322529A1 (en) | 1998-02-02 |
| AU5399096A (en) | 1996-10-23 |
| CZ313897A3 (en) | 1998-01-14 |
| JPH11503139A (en) | 1999-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199701121T1 (en) | Benazepril or combination compositions containing benazepril and valsartan. | |
| IL116385A (en) | Sulphonamides their manufacture and pharmaceutical compositions containing them | |
| DE69326776D1 (en) | USE OF N-ARYLMETHYLEN ETHYLENDIAMINTRIACETATE, N-ARYLMETHYLEN IMINODIACETAT OR N, N'-DIARYLMETHYLEN ETHYLENDIAMINDIACETAT AGAINST OXIDATIVE STRESS | |
| MY125150A (en) | Factor vlla inhibitors | |
| BR9914044A (en) | tetrahydropyride esters | |
| SE9604786D0 (en) | New compounds | |
| UA49869C2 (en) | NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, METHOD FOR TREATMENT (VARIANTS), METHOD FOR INHIBITING HUMAN FACTOR Xa OR IIa | |
| WO1996032003A3 (en) | Tetrahydroimidazopyridoindolediones and their use as medicaments | |
| IL107109A0 (en) | Compounds for modifying drug resistance and pharmaceutical compositions containing the same | |
| IL136044A (en) | 2-aminoacetamide derivatives and pharmaceutical compositions containing the same | |
| YU60900A (en) | Novel crystalline forms of an antiviral benzimidazole compound | |
| HU9603042D0 (en) | Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration | |
| DE69825164D1 (en) | MEDICINAL PREPARATIONS CONTAINING VITAMIN D AND CALCIUM, THEIR PRODUCTION AND THERAPEUTIC USE | |
| RU95111308A (en) | Derivatives of 2-amino-4-phenyl-4-oxobutyric acid, methods of synthesis, pharmaceutical composition | |
| BR9713921A (en) | Compound, pharmaceutical composition, process for logician capable of being modulated through factor xa inhibition | |
| EE9900450A (en) | Tetrahydropyrido compounds, medicament containing them and their use | |
| TR200101163T2 (en) | Bile water substituted phenyl-alkenoylguanidines, production methods, uses | |
| TR200000455T2 (en) | The use of fanquinone in the treatment of Alzheimer's disease. | |
| DE69521122D1 (en) | 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE ACID ADDITION SALTS | |
| HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| TR199801184T2 (en) | New compounds with analgesic action. | |
| GB9420747D0 (en) | 1,5 benzodiazepine derivatives | |
| GB9505082D0 (en) | Medicament | |
| HUP9801894A2 (en) | Use of dofetilide for the preparation of pharmaceutical compositions treating congestive heart failure | |
| FR2754824B1 (en) | NEW COMPOSITION CONTAINING CHITOSAN |